Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
51 /100
HIGH RISK
Score updated Oct 13, 2026

INBX — Inhibrx Biosciences, Inc. Dilution Risk Tracker

Track INBX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track INBX — Get alerts when the score changes →

As of October 13, 2026, Inhibrx Biosciences, Inc. (INBX) has a DilutionWatch DilutionScore of 51/100, rated HIGH dilution risk. Inhibrx Biosciences, Inc. has a market capitalization of $1.33B, 14.72M shares outstanding, 140 institutional holders tracked. Stored dilution-related fields include 2.00M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
30
💰 Cash Runway
65
📊 Float Risk
70
⚠️ Warrant Exposure
50
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 15%
💰 Capital Raise model 15%
• Under 12 months cash (12mo)
📜 Warrant Exercise model 15%
• Warrant overhang: 13.6% of shares outstanding
📉 Score Deterioration model 15%
• Score climbed 7 points (worsening)
🔔 Track INBX — Get forecast alerts →

Market Data

Market Cap$1.33B
Shares Outstanding14.72M
Float7.86M
Cash$133.34M
Debt$176.28M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore51/100DilutionWatch score record
Shares Outstanding14.72MVerified float table or market cache
Public Float7.86MVerified float table or market cache
Market Cap$1.33BMarket data cache
Cash Runway11.8 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants2.00MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: 8-K 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 23.8% shares (2026Q1 vs prior)
140 institutional holders · 17.29M shares
#1 PERCEPTIVE ADVISORS LLC 2.89M shares
#2 MORGAN STANLEY 2.87M shares
#3 VIKING GLOBAL INVESTORS LP 1.44M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.43M
Days to Cover11.8
% of Float43.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-19
8-K PDUFA EVENT 2026-06-15
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual INBX Dilution Snapshot

Inhibrx Biosciences, Inc. (INBX) has a DilutionScore of 51/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

INBX's DilutionScore is currently 51/100 (High risk), with 2 score changes tracked over 89 days. The score improved from 44/100 (Medium risk).

Period Score Risk Level Duration
Oct 13, 202651/100HIGH1 day
Sep 28 – Oct 12, 202644/100MEDIUM15 days
Jul 16 – Sep 27, 202640/100MEDIUM73 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

INBX shares outstanding have increased 0.9% from 14.54M (Mar 2026) to 14.67M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 19, 202614.67M7.86M▲ 0.07%
May 18, 202614.67M7.85M▲ 0.13%
May 17, 202614.67M7.84M▲ 0.44%
Mar 23, 202614.54M7.81M▲ 0.38%
Mar 21, 202614.54M7.78M▲ 0.44%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track INBX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment INBX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking INBX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for INBX
INBX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.